Oscar Gruss

NEW YORK, NY -- (MARKET WIRE) -- 11/10/08 -- China Aoxing Pharmaceutical Company, Inc. (OTCBB: CAXG) ("China Aoxing"), a China-based pharmaceutical company specializing in research, development, manufacturing and distribution of narcotic and pain-management products, today announced the newly appointed Board of Directors and the election of a new Chief Financial Officer. Comprised of individuals from both the US and China, the Board reflects a wide range of industry experience and expertise, and represents another important step toward developing China Aoxing into a world-class specialty pharmaceutical company. The newly appointed board and the new CFO have assumed their positions effective immediately. Mr. Juan Yue Han, the founder, Chairman and CEO of China Aoxing, will continue to serve in the same positions. He said, "We are honored to have the guidance and commitment of these leaders as we work toward achieving our goals. With our company growing and becoming stronger, this new Board is a wonderful mix of talent, expertise and geography. We have a ...

Oscar Gruss downgrades Ness Technologies (Nasdaq: NSTC) from Buy to Hold. Price target lowered from $14 to $7.

Oscar analyst says, "Global deceleration in IT spending is taking a ...

Oscar Gruss downgrades Radware (Nasdaq: RDWR) from Buy to Hold. Price target $7.

Oscar analyst says, "We believe 3Q08 shortfall in revenues signals an ongoing deceleration ...

Oscar Gruss upgrades RADVISION (Nasdaq: RVSN) from Hold to Buy. Price target lowered from $7 to $6.

Oscar analyst says, "We are encouraged by RVSN’s 3Q08 ...

Oscar Gruss downgrades DSP Group Inc. (Nasdaq: DSPG) to Reduce. Price target $4.50.

Oscar analyst says, "We believe the expected launch of multimedia chips and NXP post integration ...